Skip to main content
. 2021 Mar 2;25(8):3856–3869. doi: 10.1111/jcmm.16317

FIGURE 5.

FIGURE 5

Sirtinol and mitotane display synergistic inhibitory effects on adrenocortical cancer cell growth. H295R (A) and SW13 (C) cells were left untreated (basal) or treated with sirtinol (40 μmol/L) and mitotane alone (10 μmol/L) or in combination for 72 h. Cell viability was evaluated by MTT assay (*P < .05 vs basal; °P < .05 vs sirtinol; ∞P < .05 vs mitotane). (B, D) Morphological changes of H295R (B) and SW13 (D) cells after treatments. Cell images were acquired using an Inverted Microscope (magnification X100)